Back to HomeStock AnalysisPremiumAll Procter & Gamble coverage

Procter & Gamble (PG) FY2026: Net Sales $87.0B +3%, Operating Margin -160bp, Core EPS $6.89; Thorne $3.8B

Aug 13, 2026

Overview

Procter & Gamble, the world's largest consumer goods company, filed its fiscal year 2026 (July 2025–June 2026) 10-K with the SEC on August 4. In summary: revenue grew while margins compressed. Net sales reached $87.03 billion, up 3%, while operating income fell $703 million (-3%) to $19.75 billion, and operating margin contracted 160 basis points to 22.7%. Net earnings were $16.14 billion, up $79 million year over year—essentially flat—with diluted EPS of $6.62 (+2%) and the company-highlighted Core EPS of $6.89 (+1%) (10-K Summary of 2026 Results).

Unlimited U.S.-market analysis, $9.99/month

“Procter & Gamble (PG) FY2026: Net Sales $87.0B +3%, Operating Margin -160bp, Core EPS $6.89; Thorne $3.8B”

This article became available on August 13, 2026. Subscribe to read in full, or wait until November 11, 2026 when it becomes free.

Subscribe — $9.99/month

Cancel anytime. Full refund within 7 days.

Access is tied to your account. Subscribe with the same email you sign up with — if you already paid, sign up with that email and it unlocks automatically.

NewsFinanceMarkets

Go deeper than the headline

You just read what happened. Here's how to read what it means.

Free daily briefing

The U.S. market, every morning — free

LineVest Daily lands in your inbox before every opening bell: the key U.S. markets stories, earnings, disclosures and foreign flows — in plain English. Free, no card required.

Get LineVest Daily — free →

This company

Full report on Procter & Gamble

We read Procter & Gamble's latest SEC filing in full — financials under US GAAP, governance, and what it means for the stock. PDF in your inbox within 3 hours.

$12 · one-time

Get the Procter & Gamble report

Every name you watch

Follow the whole market

Reading several U.S. stocks a week? Read every analysis article the moment it publishes — full daily U.S. market coverage plus the 90-day archive.

$9.99 · monthly

Independent journalism based on primary SEC filings — not investment advice. No brokerage affiliation.

Procter & Gamble (PG) FY2026: Net Sales $87.0B +3%, Operating Margin -160bp, Core EPS $6.89; Thorne $3.8B

Unlimited U.S.-market analysis, $9.99/month

Go deeper than the headline

The U.S. market, every morning — free

Full report on Procter & Gamble

Follow the whole market

Related Stories

BlackRock (BLK) Q2 2026: $15.3T AUM, Real Margin Gain Just 86bp

Roper (ROP) Q2 2026: GAAP EPS $11.62 on $835M Indicor Gain, Core Pretax Up 0.9%

Cadence (CDNS) Q2 2026: China Revenue Up 96%, RPO $8.1B

ConocoPhillips Q2 2026: EPS Doubles to $3.23 on $104 Brent

Rockwell (ROK) Q3 FY26: Organic Sales +10%, Operating Leverage 3.0x, FY Guidance Raised to $13.15

Berkshire Hathaway (BRK.A) Q2 FY2026: Net Income +107%, Liquidity $365.5B Down $32B From Record; Abel Era Resumes Buybacks, M&A

Cisco Systems (CSCO) Q3 FY2026: Networking +25%, Inventory +49%, Q4 Revenue +18%

Thermo Fisher Scientific (TMO) Q2 2026: Revenue +10.5%, Organic Growth 5%, Cash -58% on Clario Deal

Broadcom (AVGO) Q2 FY2026: Revenue +48%, AI Chips +143%, $29B Post-Quarter Backstop

Linde (LIN) Q2 2026: Sales Up 9%, Margin Streak Ends, Stock Falls 5%

RTX Q2 2026: Backlog Hits $289B, Operating Profit Up 31%

Devon Energy (DVN) Q2 FY2026: Revenue $7.42B +73%, Net Income $1.91B +108%; Adj. EPS $1.57